Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Ying Jen

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Research and Practice in Thrombosis and Haemostasis|December 11, 2023
Venous thromboembolism in an Asian COVID-19 cohort across 3 infection waves-a retrospective observational studyShir Ying Lee, Winnie Z Y Teo, Cheryl X Q Lim, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaWei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
Human Pathology|January 25, 2026
Acute Leukemia with BCL11B Rearrangements: Genetic Landscape, BCL11B Expression, and Therapeutic ResponseGuilin Tang, Sa A Wang, Wei Ying Jen, et al.
Haematologica|July 3, 2025
PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromesAlexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, et al.
Leukemia & Lymphoma|December 6, 2023
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patientsWei-Ying Jen, Koji Sasaki, Caitlin R Rausch, et al.
Haematologica|June 26, 2025
Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell / myeloid mixed phenotype acute leukemiaRoberta S Azevedo, Wei-Ying Jen, Danielle Hammond, et al.
Heart, Lung & Circulation|March 27, 2019
Assessing the Impact of a Pulmonary Embolism Response Team and Treatment Protocol on Patients Presenting With Acute Pulmonary EmbolismWei-Ying Jen, William Kristanto, Lynette Teo, et al.
Cancer|April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemiaHagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Frontiers in Oncology|February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysisJacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Leukemia & Lymphoma|August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remissionSamuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Research and Practice in Thrombosis and Haemostasis|December 11, 2023
Venous thromboembolism in an Asian COVID-19 cohort across 3 infection waves-a retrospective observational studyShir Ying Lee, Winnie Z Y Teo, Cheryl X Q Lim, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic LeukemiaWei-Ying Jen, Elias Jabbour, Eitan Kugler, et al.
Human Pathology|January 25, 2026
Acute Leukemia with BCL11B Rearrangements: Genetic Landscape, BCL11B Expression, and Therapeutic ResponseGuilin Tang, Sa A Wang, Wei Ying Jen, et al.
Haematologica|July 3, 2025
PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromesAlexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, et al.
Leukemia & Lymphoma|December 6, 2023
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patientsWei-Ying Jen, Koji Sasaki, Caitlin R Rausch, et al.
Haematologica|June 26, 2025
Lower-intensity chemo-immunotherapy with cladribine, low-dose cytarabine, venetoclax and blinatumomab produces high response rates in patients with <i>BCR::ABL1</i>-negative B-cell / myeloid mixed phenotype acute leukemiaRoberta S Azevedo, Wei-Ying Jen, Danielle Hammond, et al.
Heart, Lung & Circulation|March 27, 2019
Assessing the Impact of a Pulmonary Embolism Response Team and Treatment Protocol on Patients Presenting With Acute Pulmonary EmbolismWei-Ying Jen, William Kristanto, Lynette Teo, et al.
Cancer|April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemiaHagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Frontiers in Oncology|February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysisJacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Leukemia & Lymphoma|August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remissionSamuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
Pageof 5